Barbara Kosacz's Insider Trades & SAST Disclosures
Barbara Kosacz's most recent trade in Athira Pharma Inc was a trade of 20,900 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 24, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Barbara Kosacz.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Athira Pharma Inc | Barbara Kosacz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2024 | 20,900 | 20,900 | - | - | Stock Option (Right to Buy) | |
| XOMA Corp | Barbara Kosacz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 9,763 | 9,763 | - | - | Non-Qualified Share Option (right to buy) | |
| Kronos Bio Inc | Kosacz Barbara | COO & General Counsel | Sale of securities on an exchange or to another person at price $ 1.18 per share. | 04 Jan 2024 | 10,676 | 928,966 | - | 1.2 | 12,636 | Common Stock |
| Athira Pharma Inc | Barbara Kosacz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 20,900 | 20,900 | - | - | Stock Option (Right to Buy) | |
| XOMA Corp | Barbara Kosacz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 10,967 | 10,967 | - | - | Non-Qualified Share Option (right to buy) | |
| Kronos Bio Inc | Barbara Kosacz | COO & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 208,367 | 208,367 | - | - | Employee Stock Option (Right to Buy) | |
| Kronos Bio Inc | Barbara Kosacz | COO & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 138,911 | 939,642 | - | 0 | Common Stock | |
| Kronos Bio Inc | Barbara Kosacz | COO & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 53,600 | 791,624 | - | 0 | Common Stock | |
| Athira Pharma Inc | Barbara Kosacz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 13,871 | 13,871 | - | - | Stock Option (Right to Buy) | |
| XOMA Corp | Barbara Kosacz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 8,996 | 8,996 | - | - | Non-Qualified Share Option (right to buy) | |
| Kronos Bio Inc | Barbara Kosacz | COO & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 80,000 | 80,000 | - | - | Employee Stock Option (Right to Buy) | |
| Kronos Bio Inc | Barbara Kosacz | COO & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 53,600 | 738,024 | - | 0 | Common Stock | |
| XOMA Corp | Barbara Kosacz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 5,101 | 5,101 | - | - | Non-Qualified Share Option (right to buy) | |
| Athira Pharma Inc | Barbara Kosacz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 27,742 | 27,742 | - | - | Stock Option (Right to Buy) | |
| Kronos Bio Inc | Barbara Kosacz | COO & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2020 | 104,736 | 104,736 | - | - | Employee Stock Option (Right to Buy) | |
| Kronos Bio Inc | Barbara Kosacz | COO & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2020 | 69,824 | 684,424 | - | 0 | Common Stock | |
| Kronos Bio Inc | Barbara Kosacz | COO & General Counsel | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 14 Oct 2020 | 5,250 | 614,600 | - | 19 | 99,750 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges